D-K6L9

D-K6L9 exhibits antimicrobial and antibiofilm properties effective against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. The compound demonstrates stability and resistance to degradation by proteases found in cystic fibrosis sputum and does not promote bacterial resistance [1].

[C@@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N)=O)=O)CC(C)C)=O)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@H](NC([C@@H](NC([C@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@@H](NC([C@H](CC(C)C)N)=O)CCCCN)=O)CC(C)C)=O)CC(C)C)=O)CCCCN)=O)CCCCN)=O)CC(C)C)=O)CC(C)C)=O)CCCCN)=O)CCCCN)=O)CC(C)C)=O)CC(C)C)=O)CCCCN